Search
for
Sort by
Research 91–120 of 749
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Idiopathic Hirsutism*
- 5α-Reduced glucocorticoids: a story of natural selection
- 5-Alpha reductase deficiency
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Novel agents for the treatment of alopecia
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- The mRNA for Protease Nexin-1 is Expressed in Human Dermal Papilla Cells and its Level is Affected by Androgen
- Adverse health effects of androgen use
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- The pathophysiology of delayed ejaculation
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Chapter 17. Selective androgen receptor modulators (SARMs)
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Therapeutic Androgen Receptor Ligands
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study
- Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature
- Finasteride and androgenic alopecia; from therapeutic options to medical implications